Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol.
Elaine W ButterlyLili WeiAmanda I AdlerSaleh A M AlmazamKhalid AlsallumiLuke A K BlackbournSofia DiasPeter HanlonKatherine HughesJames LewseyRobert LindsayStuart J McGurnaghanJohn PetrieDavid PhillippoNaveed SattarLaurie A TomlinsonNicky WeltonSarah WildDavid McAllisterPublished in: BMJ open (2022)
CRD42020184174.